ONC Insider Trading

Insider Ownership Percentage: 28.80%
Insider Buying (Last 12 Months): £19,883.91
Insider Selling (Last 12 Months): GBX 0

Oncimmune Insider Trading History Chart

This chart shows the insider buying and selling history at Oncimmune by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Oncimmune Share Price & Price History

Current Price: GBX 23.50
Price Change: Price Decrease of -1 (-4.08%)
As of 04/25/2024 01:00 AM ET

This chart shows the closing price history over time for ONC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Oncimmune Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/8/2023Martin GouldstoneInsiderBuy36,023GBX 27£9,726.21
6/5/2023Adam HillInsiderBuy48,370GBX 21£10,157.70
9/21/2022Adam HillInsiderBuy8,005GBX 62£4,963.10
3/7/2022Adam HillInsiderBuy7,533GBX 133£10,018.89
12/23/2021Adam HillInsiderBuy5,669GBX 168£9,523.92
12/21/2021Adam HillInsiderBuy5,988GBX 167£9,999.96
See Full Table

SEC Filings (Institutional Ownership Changes) for Oncimmune (LON:ONC)

35.49% of Oncimmune stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Oncimmune logo
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Leeds, the United Kingdom.
Read More on Oncimmune

Today's Range

Now: GBX 23.50
Low: 22.20
High: 24.38

50 Day Range

MA: GBX 21.56
Low: 16.80
High: 30.42

52 Week Range

Now: GBX 23.50
Low: 13
High: 45

Volume

4,000 shs

Average Volume

77,911 shs

Market Capitalization

£17.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12

Who are the company insiders with the largest holdings of Oncimmune?

Oncimmune's top insider shareholders include:
  1. Adam Hill (Insider)
  2. Martin Gouldstone (Insider)
Learn More about top insider investors at Oncimmune.